$1.05
0.03[2.94%]
At close: May 13
$1.05
0[0.00%]
PreMarket: 7:08AM EDT
Seres Therapeutics
(NASDAQ:MCRB)Seres Therapeutics Stock (NASDAQ:MCRB), Quotes and News Summary
Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 6.039K / 4.924M |
| Day Range | - - - |
| 52 Wk Range | 0.540 - 6.260 |
| Market Cap | $158.560M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 16.36% |
| Days to Cover | 4.21 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Seres Therapeutics (MCRB) stock?
You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.
Who are Seres Therapeutics's (MCRB) competitors?
Other companies in Seres Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB) and CytomX Therapeutics (NASDAQ:CTMX).
What is the target price for Seres Therapeutics (MCRB) stock?
The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Oppenheimer on Thursday, May 9, 2024. The analyst firm set a price target for 4.00 expecting MCRB to rise to within 12 months (a possible 280.95% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Seres Therapeutics (MCRB)?
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $1.05 last updated Today at May 13, 2024 at 7:08 AM EDT.
Does Seres Therapeutics (MCRB) pay a dividend?
There are no upcoming dividends for Seres Therapeutics.
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Seres Therapeutics (MCRB) going to split?
There is no upcoming split for Seres Therapeutics.
What sector and industry does Seres Therapeutics (MCRB) operate in?
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.